The Evolution of Glycemic Targets: Time in Tight Range
Screening degli autoanticorpi per la prevenzione del diabete di tipo 1
it
Prof. Emanuele Bosi
CGM improves outcomes in insulin-treated Type 2 diabetes
en
Prof. Martin de Bock
A balanced view on microbiome in obesity
en
Prof. Max Nieuwdorp
The Evolution of Glycemic Targets: Time in Tight Range
en
Prof. Viral N. Shah
Will new pharmacological treatment for obesity and early diabetes replace bariatric surgery?
en
Prof. Luca Busetto
Helping minimize the burden of living with diabetes
en
Prof. Katharine Barnard-Kelly
Impatto delle nuove tecnologie sul LADA (diabete autoimmune latente nell’adulto)
it
Prof. Ernesto Maddaloni
Diabete secondario a fibrosi cistica: ruolo dei sistemi automatici
it
Dr. Valeria Grancini